Advertisement

Vasoproliferative Tumors of the Retina

  • Duangnate RojanapornEmail author
Chapter
Part of the Retina Atlas book series (RA)

Abstract

Vasoproliferative tumors (VPT) are benign vascular tumors of the fundus which has distinct characteristics. It was firstly termed “presumed acquired retinal hemangiomas” by Shields and colleagues (Shields et al. 1983), who described 12 patients with nonfamilial, unilateral, solitary, vascular mass of the sensory retina. In 1995, they further studied a larger series of 103 patients with similar appearance and found that many of these vascular masses may not be true hemangioma and some lesions involved not only the retina but also retinal pigment epithelium and choroid. Therefore, they renamed these lesions as “vasoproliferative tumors of the ocular fundus” (Shields et al. 1995).

References

  1. Anastassiou G, Bornfeld N, Schueler AO, et al. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br J Ophthalmol. 2006;90:447–50.CrossRefGoogle Scholar
  2. Bertelli E, Pernter H. Vasoproliferative retinal tumor treated with indocyanine green-mediated photothrombosis. Retin Cases Brief Rep. 2009;3:266–71.CrossRefGoogle Scholar
  3. Blasi MA, Scupola A, Tiberti AC, et al. Photodynamic therapy for vasoproliferative retinal tumors. Retina. 2006;26:404–9.PubMedGoogle Scholar
  4. Brockmann C, Rehak M, Heufelder J, et al. Predictors of Treatment Response of Vasoproliferative Retinal Tumors to Ruthenium-106 Brachytherapy. Retina. 2016;36:2384–90.CrossRefGoogle Scholar
  5. Cohen VM, Shields CL, Demirci H, et al. Iodine I 125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes. Arch Ophthalmol. 2008;126:1245–51.CrossRefGoogle Scholar
  6. Garcia-Arumi J, Distefano LN, Fonollosa A, et al. Management of vision-threatening complications of vasoproliferative tumors of the retina. Ophthalmic Res. 2015;54:34–40.CrossRefGoogle Scholar
  7. Gibran SK. Trans-vitreal endoresection for vasoproliferative retinal tumours. Clin Exp Ophthalmol. 2008;36:712–6.CrossRefGoogle Scholar
  8. Heimann H, Bornfeld N, Vij O, et al. Vasoproliferative tumours of the retina. Br J Ophthalmol. 2000;84:1162–9.CrossRefGoogle Scholar
  9. Heimann H, Jmor F, Damato B. Imaging of retinal and choroidal vascular tumours. Eye (Lond). 2013;27:208–16.CrossRefGoogle Scholar
  10. Hussain RN, Jmor F, Damato B, et al. Verteporfin Photodynamic Therapy for the Treatment of Retinal Vasoproliferative Tumors. Ophthalmology. 2015;122:2361–3.CrossRefGoogle Scholar
  11. Irvine F, O’Donnell N, Kemp E, et al. Retinal vasoproliferative tumors: surgical management and histological findings. Arch Ophthalmol. 2000;118:563–9.CrossRefGoogle Scholar
  12. Japiassu RM, Brasil OF, Cunha AL, et al. Regression of vasoproliferative tumor with systemic infliximab. Ophthalmic Surg Lasers Imaging. 2008;39:348–9.CrossRefGoogle Scholar
  13. Kenawy N, Groenwald C, Damato B. Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin). Eye (Lond). 2007;21:893–4.CrossRefGoogle Scholar
  14. Krivosisc V, Massin P, Desjardins L, et al. Management of idiopathic vasoproliferative tumor with laser photocoagulation. Am J Ophthalmol. 2014;158:154–61.CrossRefGoogle Scholar
  15. Manjandavida FP, Shields CL, Kaliki S, et al. Cryotherapy-induced release of epiretinal membrane associated with retinal vasoproliferative tumor: analysis of 16 cases. Retina. 2014;34:1644–50.CrossRefGoogle Scholar
  16. McCabe CM, Mieler WF. Six-year follow-up of an idiopathic retinal vasoproliferative tumor. Arch Ophthalmol. 1996;114:617.CrossRefGoogle Scholar
  17. Nomura Y, Tamaki Y, Tsuji H, et al. Transpupillary thermotherapy for vasoproliferative retinal tumor. Retin Cases Brief Rep. 2009;3:358–60.CrossRefGoogle Scholar
  18. Poole Perry LJ, Jakobiec FA, Zakka FR, et al. Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases. Am J Ophthalmol. 2013;155:593–608.CrossRefGoogle Scholar
  19. Rogers C, Damato B, Kumar I, et al. Intravitreal bevacizumab in the treatment of vasoproliferative retinal tumours. Eye (Lond). 2014;28:968–73.CrossRefGoogle Scholar
  20. Saito W, Kase S, Fujiya A, et al. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. Retina. 2013;33:1959–67.CrossRefGoogle Scholar
  21. Shields JA, Decker WL, Sanborn GE, et al. Presumed acquired retinal hemangiomas. Ophthalmology. 1983;90:1292–300.CrossRefGoogle Scholar
  22. Shields CL, Shields JA, Barrett J, et al. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol. 1995;113:615–23.CrossRefGoogle Scholar
  23. Shields CL, Kaliki S, Al-Dahmash S, et al. Retinal vasoproliferative tumors: comparative clinical features of primary vs secondary tumors in 334 cases. JAMA Ophthalmol. 2013;131:328–34.CrossRefGoogle Scholar
  24. Yeh S, Wilson DJ. Pars plana vitrectomy and endoresection of a retinal vasoproliferative tumor. Arch Ophthalmol. 2010;128:1196–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Ophthalmology, Faculty of MedicineRamathibodi Hospital, Mahidol UniversityBangkokThailand

Personalised recommendations